Q32 Bio (QTTB) Capital Expenditures (2017 - 2025)

Q32 Bio's Capital Expenditures history runs 9 years deep, the most recent figure standing at $1.1 million for Q4 2025.

• On a quarterly basis, Capital Expenditures rose 324.02% year-over-year to $1.1 million in Q4 2025; TTM through Mar 2026 was $633000.0, a 40.79% decrease from a year earlier, with the FY2025 full-year figure at $961000.0, up 12.27% from the prior year.
• Capital Expenditures climbed to $1.1 million in Q4 2025 per QTTB's latest filing, from -$622000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $2.4 million in Q4 2021 and bottomed at -$1.5 million in Q3 2021.
• The 5-year median for Capital Expenditures is $115000.0 (2024), against an average of $289631.6.
• Biggest YoY gain for Capital Expenditures was 58600.0% in 2024; the steepest drop was 470.37% in 2024.
• Year by year, Capital Expenditures stood at $2.4 million in 2021, then tumbled by 99.62% to $9000.0 in 2022, then tumbled by 88.89% to $1000.0 in 2023, then jumped by 25300.0% to $254000.0 in 2024, then jumped by 324.02% to $1.1 million in 2025.
• Per Business Quant, the three latest QTTB Capital Expenditures figures stand at $1.1 million (Q4 2025), -$622000.0 (Q3 2025), and $178000.0 (Q2 2025).